Novartis’ rare renal disease candidate shows promise in phase II
Investigational oral treatment is being investigated in C3 glomerulopathy
Read More
Tag: ASN 2020
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
Read More
- Pluripotent stem cell trial for Huntington’s disease
- Jascayd gains UK licence for treatment of pulmonary fibrosis
- Grünenthal receives FDA designations for tegacorat in Duchenne muscular dystrophy
- Compass Pathways reports six‑month data confirming durable profile of COMP360
- Ferrer and Prilenia begin confirmatory study of pridopidine in Huntington’s disease
